Cargando…
A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA
INTRODUCTION: If their target glycated hemoglobin (HbA(1c)) is not achieved after 3 months, timely treatment intensification is recommended in people with type 2 diabetes to maintain glycemic control and minimize vascular complications. We retrospectively investigated potential therapeutic inertia i...
Autores principales: | Rattelman, Cori R., Ciemins, Elizabeth L., Stempniewicz, Nikita, Mocarski, Michelle, Ganguly, Rahul, Cuddeback, John K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846632/ https://www.ncbi.nlm.nih.gov/pubmed/33460018 http://dx.doi.org/10.1007/s13300-020-00993-w |
Ejemplares similares
-
Successful Implementation of an All-or-None Diabetes Measure in 10 US Health Systems
por: Grant, Cori Cohen, et al.
Publicado: (2022) -
Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations
por: Stempniewicz, Nikita, et al.
Publicado: (2021) -
Nonadherence, Clinical Inertia, or Therapeutic Inertia?
por: Allen, J. Daniel, et al.
Publicado: (2009) -
Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association
por: Gabbay, Robert A., et al.
Publicado: (2020) -
Measuring What Matters: Beyond Quality Performance Measures in Caring for Adults with Obesity
por: Ciemins, Elizabeth, et al.
Publicado: (2021)